Catalog Number VS-402 |
Device Problem
Biocompatibility (2886)
|
Patient Problems
Unspecified Infection (1930); Ulceration (2116)
|
Event Date 04/17/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
During procedure, venaseal occluding device was used to treat 7 segments in the great saphenous vein (gsv) in one leg without incident.Patient then received venaseal again and about 4 - 6 weeks after treatment, complained of redness by the access site.Patient was instructed to take medtrol dose pack and contact clinic if symptoms persist.It was discovered that the patient did not take the dose pack nor contacted the office.Patient presented to dermatologist and was placed on antibiotics.The patient has taken the antibiotics prescribed by the dermatologist.Patient is now about 18 months out of treatment date and complaining of slight ulceration and possible e.Coli infection.No further patient injury reported.
|
|
Manufacturer Narrative
|
Additional information: both left and right legs were treated on the same date.The patient first presented with symptoms 4-6 weeks post procedure.The patient is scheduled for a follow-up visit.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Additional information: the patient is reported to be doing much better.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Additional information: the physician reported presence of adhesive at the access site resulting in a 2 cm dark lesion, on one of the 2 legs treated.No issues with the other leg.Patient was not seen in the practice for 18 months, so physician assumed the patient was doing fine.She returned to the facility presenting some minor issues at the access site.Patient was seen by a plastic surgeon to see about removing/exploring the site.This has been performed and patient was left with a small scar.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|